BT Lab
SKU:BT-AP00279
Adipsin Rabbit Polyclonal Antibody
Adipsin Rabbit Polyclonal Antibody
Couldn't load pickup availability
Catalytic activity:Selective cleavage of Arg-|-Lys bond in complement factor B when in complex with complement subcomponent C3b or with cobra venom factor.|disease:Defects in CFD are the cause of complement factor D deficiency
The Adipsin Rabbit Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of adipsin protein in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to a specific region of the adipsin protein.
Adipsin, also known as complement factor D, is a serine protease that plays a crucial role in the alternative pathway of the complement system. It is primarily expressed in adipose tissue and is involved in adipogenesis, lipid metabolism, and inflammation. Dysregulation of adipsin has been implicated in various metabolic disorders, including obesity, diabetes, and cardiovascular diseases.
The Adipsin Rabbit Polyclonal Antibody exhibits high affinity and specificity towards adipsin protein, ensuring accurate and reliable results in various applications, such as Western blotting, immunohistochemistry, and enzyme-linked immunosorbent assays (ELISA). It recognizes both the pro-form and active form of adipsin, allowing for comprehensive analysis of adipsin expression and activation.
This antibody has been extensively validated and optimized for use in various species, including human, mouse, and rat. It demonstrates minimal cross-reactivity with other related proteins, ensuring specific detection of adipsin without interference from homologous proteins.
With its superior sensitivity and specificity, the Adipsin Rabbit Polyclonal Antibody is an indispensable tool for researchers and clinicians studying the role of adipsin in various physiological and pathological processes. Its reliable performance and consistent results make it an ideal choice for investigating adipsin-related disorders and developing potential therapeutic interventions.
Share
